Why Magnera Stock Exploded Higher Today

Magnera (MAGN) reported Q3 FY2026 net sales of $857 million, up 2% from $839 million, with organic volume growth of 1%. Non-GAAP adjusted EBITDA rose to $99 million. Full-year free cash flow guidance is $90 million to $110 million, and liquidity was $575 million. Total debt was $1.9 billion. Risks cited include faster raw-material inflation and weaker Europe demand.

Magnera (NYSE:MAGN) reported Q3 updates on infrastructure and filtration-related sales, with Americas revenue essentially flat year over year. Adjusted EBITDA rose 16% to $71 million in the Americas. The company reaffirmed full-year free cash flow of about $90M to $110M, but expects full-year adjusted EBITDA toward the low end of its prior range, citing inflation and macro uncertainty.

Magnera Corp (MAGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release Magnera Reports Third Quarter Third Quarter Highlights • GAAP: Net sales of $857 million, Operating income of $22 million • Non-GAAP: Adjusted EBITDA of $99 million • Twelve-month adjusted free cash flow yield of greater than 25% as of quarter-end Curt B

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.